Form 8-K - Current report:
SEC Accession No. 0001104659-22-070104
Filing Date
2022-06-10
Accepted
2022-06-10 16:05:14
Documents
12
Period of Report
2022-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218031d1_8k.htm   iXBRL 8-K 33788
  Complete submission text file 0001104659-22-070104.txt   206574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20220608.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20220608_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20220608_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2218031d1_8k_htm.xml XML 3482
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 221008837
SIC: 2834 Pharmaceutical Preparations